Li Li

Li Li

Net worth: 786 M $ as of 31/05/2026

62 year
Health Technology
Consumer Services
Technology Services

Profile

Li Li is a businessperson who founded Shenzhen Hepalink Pharmaceutical Group Co., Ltd. and who has been at the head of 5 different companies. Presently, he holds the position of Chairman for Shenzhen Techdow Pharmaceutical Co., Ltd. and Chairman at Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Chairman & Chief Executive Officer of Hepalink USA, Inc. and Chairman for Shenzhen Duopule Industrial Development Co., Ltd. (both are subsidiaries of Shenzhen Hepalink Pharmaceutical Group Co., Ltd.). He is also on the board of Cytovance Biologics, Inc. (former Chairman), Shenzhen Leren Technology Co. Ltd. and Urumqi Feilaishi Equity Investment Co. Ltd. Mr. Li received an undergraduate degree from Sichuan University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/09/2025 51,43,49,899 ( 41.24% ) 755 M $ 31/05/2026
30/06/2025 7,78,04,710 ( 13.62% ) 30 M $ 31/05/2026

Li Li active positions

CompaniesPositionStart
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. Founder 21/04/1998
Director/Board Member -
Urumqi Feilaishi Equity Investment Co. Ltd.
Director/Board Member -
Shenzhen Techdow Pharmaceutical Co., Ltd.
Chairman -
Chief Executive Officer -
Chairman 13/01/2014
Director/Board Member -
Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Chairman -

Former positions of Li Li

CompaniesPositionEnd
HIGHTIDE THERAPEUTICS, INC. Director/Board Member 02/02/2024
See the detail of Li Li's experience

Training of Li Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Health Technology

Technology Services

Urumqi Feilaishi Equity Investment Co. Ltd.

Shenzhen Techdow Pharmaceutical Co., Ltd.

Health Technology

Distribution Services

Health Technology

Shenzhen Arimab Biopharmaceuticals Co., Ltd.